Allele Imbalance or Loss of Heterozygosity in Normal-Appearing Breast Epithelium as a Novel Marker to Predict Future Breast Cancer

doi 10.21236/ada474710

Full Text

Abstract

Available in

Date

Authors

Publisher

Defense Technical Information Center

Related search

Loss of Heterozygosity on Chromosome 1q in Human Breast Cancer.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Loss of Pigment Epithelium-Derived Factor: A Novel Mechanism for the Development of Endocrine Resistance in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2012English

Metaplastic Breast Cancer in a Patient With Neurofibromatosis Type 1 and Somatic Loss of Heterozygosity

Cold Spring Harbor molecular case studies
BiochemistryMolecular MedicineGenetics
2018English

S100β as a Serum Marker in Endocrine Resistant Breast Cancer

BMC Medicine
Medicine
2017English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Systematic Review to Establish the Frequency of Cyclooxygenase-2 Expression in Normal Breast Epithelium, Ductal Carcinoma in Situ, Microinvasive Carcinoma of the Breast and Invasive Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Loss of PEDF: A Novel Mechanism of Antihormone Resistance in Breast Cancer

2013English

Loss of Heterozygosity on Chromosome Arm 16q in Breast Cancer: Clinical, Molecular and Statistical Approaches

Breast Cancer Research
Cancer ResearchOncology
2000English

ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy